Mar 3, 2015 | Inside, Research
Joshua D. Rosenberg, MD, Assistant Professor of Otolaryngology at Icahn School of Medicine at Mount Sinai, is one of only a handful of U.S. surgeons who is using an innovative new procedure to restore the ability to smile in patients with facial paralysis.
The procedure, called cranial nerve V and VII transfer, helps to ameliorate the disfiguring effects of severe Bell’s palsy and, to a lesser extent, certain head and neck cancers. It calls for the surgeon to reroute the patient’s robust masseter nerve—which activates the chewing muscles—in order to power the paralyzed facial nerves and restore facial muscle function, specifically the muscles involved in smiling. (more…)
Mar 3, 2015 | Inside, Research
Two studies published recently in the Proceedings of the National Academy of Sciences, led by researchers at the Icahn School of Medicine at Mount Sinai, demonstrate how widely used, inexpensive medications to treat osteoporosis, known as bisphosphonates, have the potential to become potent cancer-fighting drugs. (more…)
Mar 3, 2015 | Inside, Research, School
Eric Oermann, MD, a pioneering Neurosurgery second-year resident at Icahn School of Medicine at Mount Sinai, has been named to the fourth annual Forbes “30 Under 30” list as one of the nation’s top Health Care innovators for 2015. According to Forbes, the honorees “reflect the best and the brightest in health care and science.” (more…)
Mar 3, 2015 | Inside, Research
Seminal research led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology, and Medicine (Clinical Immunology), at Icahn School of Medicine at Mount Sinai, has identified the key drivers of eczema and given rise to promising new treatments that appear to reverse the disease. (more…)
Updated on Jun 30, 2022 | Inside, Research, School
Researchers at the Icahn School of Medicine at Mount Sinai have identified 53 drugs approved for use in treating depression, cancer, heart disease, and other illnesses that may also be effective in fighting the Ebola virus. The findings appeared online in the December 17, 2014, journal Emerging Microbes & Infections. (more…)
Updated on Jun 30, 2022 | Inside, Research
Seminal research led by James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, has produced a promising approach to treating patients with graft-versus-host disease (GVHD)—a sometimes fatal complication of bone marrow transplantation in which the donor’s immune cells attack the recipient’s body. Bone marrow transplants are often used to treat patients with leukemia, lymphoma, and other blood diseases. (more…)
Joshua D. Rosenberg, MD, Assistant Professor of Otolaryngology at Icahn School of Medicine at Mount Sinai, is one of only a handful of U.S. surgeons who is using an innovative new procedure to restore the ability to smile in patients with facial paralysis.
